B. Mesquita

发表

Expression changes of the ETS family of transcription factors associated with chromosomal rearrangements in breast cancer.

B. Mesquita, 2013 .

Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes

R. Lothe, G. Lind, D. Pereira, 2013, Breast Cancer Research and Treatment.

Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer

Crispin J. Miller, Christopher Smowton, Yaoyong Li, 2016, Nature Medicine.

Molecular analysis of single circulating tumour cells following long‐term storage of clinical samples

R. Marais, C. Dive, F. Blackhall, 2017, Molecular oncology.

Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse

Crispin J. Miller, Nicolai J. Birkbak, Angela E. Leek, 2019, Nature Medicine.

TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes

P. Soares, M. Sobrinho-Simões, Joana Lyra, 2016, Scientific Reports.

articleChromosome copy number changes carry prognostic information independent of KIT / PDGFRA point mutations in gastrointestinal stromal tumors

C. Lopes, M. Soares, M. Teixeira, 2015 .

Open Access Research Article Chromosome Copy Number Changes Carry Prognostic Information Independent of Kit/pdgfra Point Mutations in Gastrointestinal Stromal Tumors

C. Lopes, M. Soares, M. Teixeira, 2022 .

A novel exonic rearrangement affecting MLH1 and the contiguous LRRFIP2 is a founder mutation in Portuguese Lynch syndrome families

R. Henrique, M. Teixeira, A. Peixoto, 2011, Genetics in Medicine.

No significant role for beta tubulin mutations and mismatch repair defects in ovarian cancer resistance to paclitaxel/cisplatin

D. Pereira, M. Teixeira, S. Castedo, 2005, BMC Cancer.

The MSH2 c.388_389del mutation shows a founder effect in Portuguese Lynch syndrome families

S. Farrington, R. Henrique, D. Evans, 2013, Clinical genetics.

Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer.

Sumitra Mohan, Mahmood Ayub, Dominic G Rothwell, 2016, The Analyst.

MSH6 germline mutations in early-onset colorectal cancer patients without family history of the disease

C. Lopes, C. Jerónimo, M. Teixeira, 2006, British Journal of Cancer.

Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer

Crispin J. Miller, Christopher Smowton, Yaoyong Li, 2016, Nature Medicine.